Analyst Ratings for Insmed (INSM)
INSM Rating Summary
INSM Price Target Summary
- Highest: $263.00 (Rothschild Redburn)
- Lowest: $160.00 (Evercore ISI)
- Average: $208.91
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$208.91 (+92.9%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$208.91 (+92.9%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
180.00 (N/A) |
107.15 (108.32) |
1.09% | Details |
| 4/9/2026 | Raymond James | Tiago Fauth | New Coverage | Outperform (N/A) |
200.00 (N/A) |
160.18 (108.32) |
-32.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
